BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7032923)

  • 1. A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
    Rørth M; Løber J; Dombernowsky P; Krusenstjerna-Hofstrom D; Mattsson W; Mouridsen HT
    Eur J Cancer (1965); 1980; Suppl 1():137-40. PubMed ID: 7032923
    [No Abstract]   [Full Text] [Related]  

  • 2. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
    Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
    Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prednimustine in advanced breast cancer: a review.
    Mouridsen HT
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):27-31. PubMed ID: 3513318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancer.
    Rankin EM; Harvey C; Knight RK; Rubens RD
    Cancer Treat Rep; 1987 Nov; 71(11):1107-8. PubMed ID: 3119205
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer.
    Mouridsen HT; Kristensen D; Nielsen JH; Dombernowsky P
    Cancer; 1980 Jul; 46(2):253-5. PubMed ID: 7388770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premarin priming before prednimustine, high-dose folinic acid and 5-fluorouracil as salvage chemotherapy for advanced breast cancer.
    Marini G; Simoncini E; Marpicati P; Montini E; Ferrari V; Arcangeli G; Zaniboni A
    Chemioterapia; 1988 Apr; 7(2):130-2. PubMed ID: 2840216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prednimustine in advanced malignant melanoma: a phase II study.
    Pedersen L; Løber J; Dalmark M; Mouridsen HT
    Cancer Treat Rep; 1987 Dec; 71(12):1315-6. PubMed ID: 3690549
    [No Abstract]   [Full Text] [Related]  

  • 8. Prednimustine in combination with methotrexate and 5-FU (PMF): a pilot study.
    Boesen E; Mouridsen HT
    Cancer Treat Rep; 1982 Dec; 66(12):2081-3. PubMed ID: 7139649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of Leo 1031 (prednimustine) in advanced ovarian carcinoma.
    Johnsson JE; Tropé C; Mattsson W; Grundsell H; Aspegren K; Könyves I
    Cancer Treat Rep; 1979 Mar; 63(3):421-4. PubMed ID: 371798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary clinical study of prednimustine in lung cancer.
    Catane H; Catane R; Takita H; Kaufman JH; Mittelman A; Murphy GP
    J Med; 1977; 8(2):115-21. PubMed ID: 268397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prednimustine treatment in malignant lymphomas.
    Szántó I; Fleischmann T; Eckhardt S
    Oncology; 1989; 46(4):205-7. PubMed ID: 2662086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of Prednimustine. Leo-1031 (NSC-134087) in acute non-lymphocytic leukemia.
    Juul K; Sørensen P; Pedersen-Bjergaard J; Jensen MK
    Scand J Haematol; 1979 Nov; 23(5):388-92. PubMed ID: 396664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized comparative study of prednimustine and doxorubicin in patients with metastatic breast cancer.
    Allegra JC
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):42-4. PubMed ID: 3513319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A phase II study of prednimustine in advanced ovarian cancer].
    Grundsell H; Johnsson JE; Tropé C
    Lakartidningen; 1980 Sep; 77(39):3394-7. PubMed ID: 6161283
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II trial of prednimustine in glioblastoma multiforme.
    Andersen J; Christensen L; Kongsholm H
    Cancer Treat Rep; 1984 May; 68(5):795-7. PubMed ID: 6327038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroids and alkylating agents.
    Pedersen-Bjergaard J; Hansen MM; Geisler CH; Nissen NI
    Acta Med Scand; 1980; 207(3):215-20. PubMed ID: 6989170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma.
    Leonard RC; Smart GE; Livingstone JR; Cornbleet MA; Kerr GR; Fletcher S; Webb JN; Smyth JF
    Cancer Chemother Pharmacol; 1989; 23(2):105-10. PubMed ID: 2491962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined leukeran-prednisolone therapy in metastasizing breast cancer].
    Cziráki L; Oó M
    Fortschr Med; 1977 Apr; 95(15):1043-6. PubMed ID: 858580
    [No Abstract]   [Full Text] [Related]  

  • 19. Prednimustine in elderly patients with multiple myeloma: a phase II study.
    Tirelli U; Sorio R; Magri MD; Zagonel V; Vaccher E; Carbone A; Trovò M; Grigoletto E
    Cancer Treat Rep; 1986 Apr; 70(4):537-8. PubMed ID: 3698051
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant chemotherapy with chlorambucil and 5-fluorouracil in primary breast cancer (Cooperative Study Heidelberg).
    Kaufmann M; Fournier DV; Sievers H; Staib I; Wöllgens P; Nedden R; Lochbühler H; Queisser W; Christmann D; Bühner R; Pfuhl PJ; Henningsen B; Kuttig H; Wysocki S; Thüre D; Köhler C; Drings P
    Eur J Cancer (1965); 1980; Suppl 1():157-60. PubMed ID: 7032925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.